Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention
Launched by FRENCH NATIONAL AGENCY FOR RESEARCH ON AIDS AND VIRAL HEPATITIS · Jul 27, 2017
Trial Information
Current as of July 03, 2025
Unknown status
Keywords
ClinConnect Summary
The CO1-EPF prospectively enrolled HIV-infected women who deliver in 25 centers throughout France, except in case of refusal.
Maternal clinical, biological and therapeutic data before and during pregnancy are collected at delivery. The children are examined clinically and biologically at birth, 1, 3, 6, 12 and 24 months. An infant is considered as non infected if two virologic tests are negative beyond the prophylactic treatment or serology is negative after 18 months. An infant is considered as infected if HIV1 is detected by virologic tests on two occasions (polymerase chain reactions, v...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women \>= 18 years
- • infected with HIV1 and/or HIV2
- Exclusion Criteria:
- • -
About French National Agency For Research On Aids And Viral Hepatitis
The French National Agency for Research on AIDS and Viral Hepatitis (ANRS) is a prominent public institution dedicated to advancing research and innovation in the fields of HIV/AIDS and viral hepatitis. Established to enhance the understanding, prevention, and treatment of these diseases, ANRS plays a crucial role in coordinating and funding clinical trials, fostering collaboration among researchers, healthcare professionals, and institutions. By promoting high-quality scientific research and facilitating access to cutting-edge therapies, ANRS aims to improve patient outcomes and inform public health policies, ultimately contributing to the global fight against viral infections.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Paris, , France
Bondy, , France
Lyon, , France
Creteil, , France
Marseille, , France
Paris, , France
Clamart, , France
Paris, , France
Lyon, , France
Nantes, , France
Paris, , France
Paris, , France
Paris, , France
Lille, , France
Montpellier, , France
Montreuil, , France
Nice, , France
Paris, , France
Saint Denis, , France
Toulouse, , France
Argenteuil, , France
Clichy, , France
Colombes, , France
Corbeil Essonnes, , France
Le Kremlin Bicetre, , France
Paris, , France
Strasbourg, , France
Patients applied
Trial Officials
Josiane Warszawski
Principal Investigator
CESP INSERM U1018
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials